NEW DELHI: Days after India’s drug regulator suspended manufacturing and marketing permission of Mumbai-based ETOD Pharmaceuticals, which had claimed that their new eye drop reduced dependency ...
Any future launch of PresVu eye drops would include nationwide academic sessions with eye doctors, the company claimed. (Image Credits: Pixabay) Mumbai-based ENTOD Pharmaceuticals on Thursday ...
Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. I'm a Fitness & Nutrition ...
Ciclosporin 0.1% eye drops solution will be marketed under the brand name Vevizye in the EU for the treatment of dry eye ...
The American Academy of Ophthalmology recommends eye examinations at least every year or two after age 65. Age-related eye ...
Cipla (₹1,595.25): The stock has been in a strong uptrend since March 2020 within intermediate corrections. This uptrend is intact. The share price touched a new high of ₹1,702 and has come ...
Last October was an FDA approval. This October is a $68 million fundraising round. Next year, maybe a drug launch. Orasis ...
Cipla Health Ltd, the wholly-owned subsidiary and consumer healthcare arm of Cipla, is evaluating a majority stake purchase in a private equity-backed nutrition brand as part of the parent company&#39 ...
At around 2.45 pm on October 10, the index was down 2.14 percent with Lupin, Torrent Pharma, Cipla and Alkem Laboratories among major laggards. "Stocks such as Divi's Laboratories, Glenmark and ...
Harvard Health Publishing on MSN8d
Color-changing eye drops: Are they safe?
As the adage goes, the eyes are the windows to the soul. The answer is a hard no, according to the American Academy of Ophthalmology, which recently issued a warning against "eye color-changing ...
The recent approval of Vuity by the Food and Drug Administration marks a significant advancement in treating presbyopia, a ...
A Canadian pharmaceutical company is warning consumers not to use some of its eye drops because of potential microbial growth that may result in eye infections. Montreal-based Pendopharm ...